One Step Nearer to Taxol

Although Taxol® (paclitaxel) offers significant benefits to cancer patients, its initial isolation from the bark of the Pacific yew tree (Taxus brevifolia) raised serious ecological concerns since the trees are killed in the harvesting process. These concerns led to the

Tagged with:
Posted in News

Blocking Cancer Networks

The emergence of drug resistance is one of the main causes of failure in cancer treatment and is one reason that cancer drugs are often used in combination. Resistance can also arise during the use of combinations of cytotoxic agents

Tagged with: ,
Posted in News

Study Casts New Light on Prozac Mechanism

Selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine (Prozac®) have been used to treat depression for more than three decades but researchers from INSERM and Hoffmann-La Roche have now shed new light on their mechanism of action. SSRIs are believed

Tagged with: ,
Posted in News

The BMK1 Pathway in Oncology – a Road Less Travelled

Of the four mammalian MAP kinase pathways (ERK1/2, JNK, p38 and BMK1), BMK1 is the least studied. BMK1 and ERK1/2 pathways are both activated by mitogens and oncogenic signals and are therefore implicated in tumorigenesis. Indeed, the ERK1/2 pathway has

Tagged with: , , ,
Posted in News

Possible Biomarker for COX-2 Cardiovascular Risk

Selective COX-2 inhibitors were developed to minimise the adverse gastrointestinal effects seen with conventional NSAIDs and have provided effective pain relief for millions of arthritis patients. Long-term, high dosage use of some COX-2 inhibitors, however, was found to be associated

Tagged with: , ,
Posted in News

Speeding the Cellular Waste Disposal System

The ubiquitin-proteasome system (UPS) is a critical element of the cellular machinery, responsible for removing unwanted proteins. Target proteins, which may be misfolded, oxidised or simply no longer required, are marked for degradation by attachment of ubiquitin chains. The ubiquitinated

Tagged with: ,
Posted in News

2-AG – Not Such Eternal Bliss?

The cannabinoid receptors, CB1 and CB2, were first identified as the receptors for the active components of Cannabis sativa. The endogenous ligands for the cannabinoid receptors, anandamide (from ananda, a Sanskrit word meaning ‘bliss’) and 2-arachidonoylglycerol (2-AG), exert most of

Tagged with: ,
Posted in News

LRRK2 Inhibitor Protective in Parkinson’s Disease Model

The main symptoms of Parkinson’s disease are tremor, rigidity and involuntary movement, caused by loss of dopaminergic neurons in the brain. Leucine-rich repeat protein kinase-2 (LRRK2) is mutated in a significant number of Parkinson’s disease cases, both familial and sporadic

Tagged with: , ,
Posted in News

How Arthritis May Protect Against Alzheimer’s Disease

Epidemiological studies have suggested that either rheumatoid arthritis itself – or the anti-inflammatory drugs used to control it – are associated with a reduced risk of developing Alzheimer’s disease. Recent clinical trials with non-steroidal anti-inflammatory drugs (NSAIDs) have failed to

Tagged with: , ,
Posted in News

Stomach Bugs Need Vitamin B6

Approximately half of the world’s population is infected with Helicobacter pylori, the bacterium that causes peptic ulcers and some forms of stomach cancer. Although ‘triple therapy’ with a proton pump inhibitor and two antibiotics – selected from a very limited

Tagged with: , ,
Posted in News
Archives

Recent Comments

  • Role for HDAC3 in Friedreich’s Ataxia (103)
    • mona: HELLO DEAR FRIENDS GOOD NEWS FOR YOU! POSITIVE RESULTS FROM FIRST CLINICAL TRIAL OF RG2833( HDACi) THANKS GOD!...
    • MONA: hello friends , GOOD NEWS FOR YOU! POSITIVE RESULTS! http://quest.mda.org/news/fa-r g2833-well-tolerated-incr...